Full-Time

AVP – Quantitative Market Risk Analyst

Confirmed live in the last 24 hours

Citigroup

Citigroup

10,001+ employees

Global financial services and banking solutions

Compensation Overview

$96.4k - $144.6k/yr

+ Incentive Awards + Retention Awards

Junior, Mid

Irving, TX, USA

Category
Quantitative Analysis
Quantitative Research
Quantitative Finance
Required Skills
Python
SQL
Hadoop
Linux/Unix
Data Analysis
Requirements
  • Master’s degree in Finance, Computer Science, Statistics, or another quantitative field (Mathematics, Engineering, Econometrics, Economics, etc.) is required.
  • Demonstrable interest in applying sophisticated mathematical and analytical techniques to solve real-world problems—especially in banking, finance, or risk management—is required.
  • Solid programming skills, with experience of statistical/data analysis techniques and numerical implementations and some familiarity of modern software development tools, is required.
  • Good written and verbal communication skills, with ability to synthesize complex technical information and explain it clearly, is required.
Responsibilities
  • With oversight/guidance from senior staff, research, analyze, develop codes, and document market risk models for Basel 3 FRTB projects.
  • Conduct data exploration on historical market data to understand data features.
  • Provide comprehensive interpretations, explanations, and conclusions based on a set of analytic results.
  • Develop, validate, and improve SQL queries for all kinds of market data.
  • Develop models and validate Python and PySpark codes.
  • Execute consistently to Model Risk Management heightened standards.
  • Assist others in technology issues on Hadoop platform, Linux, and Windows OS systems.
Desired Qualifications
  • Experience or knowledge of big data development is highly advantageous.
  • Specific experience in Python, PySpark, Hadoop, using statistical packages and regression models, Linux, databases, SQL, and git is particularly advantageous.
  • 2+ years quantitative analytical experience preferred. Other experience in financial institutes considered.

Citigroup provides a wide range of financial services, including consumer banking, corporate and investment banking, securities brokerage, and wealth management. The company operates in over 160 countries, allowing it to serve a diverse clientele that includes individuals, small businesses, large corporations, and government entities. Citigroup's services work by offering loans, managing investments, and facilitating transactions, all while generating revenue through interest, fees, and trading activities. What sets Citigroup apart from its competitors is its extensive global network and focus on technological advancements that enhance the banking experience. The company's goal is to create a positive financial and social impact through its services while maintaining growth and profitability.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1812

Simplify Jobs

Simplify's Take

What believers are saying

  • Citi's leadership in debt syndication strengthens its position in corporate banking.
  • Investments in AI and machine learning enhance risk management and fraud detection capabilities.
  • Partnerships with fintechs like Validis modernize business lending and improve decision-making.

What critics are saying

  • Competition from fintechs like Nammu21 threatens Citi's traditional banking services.
  • Alternative funding platforms like Capital on Tap may divert clients from Citi.
  • Rapid growth of DeFi platforms challenges traditional banking models, requiring adaptation.

What makes Citigroup unique

  • Citi's global presence in over 160 countries sets it apart from competitors.
  • Strong focus on ESG initiatives enhances Citi's reputation and attracts socially conscious investors.
  • Technological innovation in digital banking solutions boosts customer engagement and satisfaction.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-5%

2 year growth

-5%
Finance Director Europe
Mar 18th, 2025
Nammu21 announces strategic investments from Nasdaq Ventures, State Street, and UBS

With fully automated technology, Nammu21 streamlines loan operations, improves productivity by eliminating the inefficiencies of manual inputs across legacy operating systems

The Asset
Feb 27th, 2025
Citigroup leads US$850 million debt syndicate for Danaos

New York-listed Danaos Corporation has signed a syndicated loan amounting to US$850 million for the financing of 14 containerships being built in Chinese yards.

FF News
Feb 20th, 2025
Capital on Tap Secures £750 Million in Landmark Funding Facilities to Accelerate Small Business Growth

Capital on Tap has secured major funding facilities for its card totalling £750 million to fuel expansion and support for small businesses

FF News
Feb 11th, 2025
Proxymity Secures $26M Funding Boost

Proxymity has secured $26 million in additional growth funding from existing investors, including BNP Paribas, BNY, Citi, Clearstream, Computershare, J.P. Morgan, and State Street. This funding supports Proxymity's innovative technology in proxy voting and shareholder communications. The capital will enhance technology and support geographic expansion. Investors express confidence in Proxymity's potential and its impact on transparency and efficiency in investor communications.

Capital Riesgo
Jan 22nd, 2025
Anaconda BioMed secures €3.6M investment

In December, Innvierte, promoted by CDTI Innovación, invested €171 million in 16 co-investments and two investment vehicles. Notably, Anaconda BioMed received a €3.6 million commitment from CDTI Innovación, alongside other investors, to enhance its advanced catheter systems for ischemic stroke treatment. Additionally, CDTI committed €10 million to Oncomatryx Biopharma and €1.734 million to Payload Aerospace.